课题基金 / 基金详情

Mammary Prolactin Production and Breast Cancer

Mammary Prolactin Production and Breast Cancer
乳腺催乳素的产生与乳腺癌
批准号:
6803512
负责人:
LINDA A. SCHULER
金额:
$25.46万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2006-08-31

项目摘要

项目成果

LINDA A. SCHULER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):虽然催乳素(PRL)在正常乳腺中扮演着重要的角色,但它在人类乳腺癌中的作用仍然知之甚少。尽管PRL受体在人类肿瘤中升高,但循环PRL与疾病的流行病学研究一直不一致,而用溴隐亭阻断垂体PRL的临床效果并不一致。然而,在这些研究中,人类乳房组织中局部产生的催乳素,允许自分泌/旁分泌活动,并未涉及。在之前的授权期中,我们展示了PRL通过调节细胞周期蛋白D1和p21的表达在体外刺激乳腺细胞周期,并描述了协调这一过程的一系列信号通路。此外,体内乳腺上皮细胞内PRL的过表达导致肿瘤的发生,并且PRL影响TGFa诱导的乳腺癌的发生以减少肿瘤的潜伏期。我们的发现支持PRL在乳腺癌增殖增加中的作用,并提供了模型来检验这种疾病的机制和与其他因素的相互作用。假设:催乳素和雌二醇通过刺激细胞周期调节剂的表达和活性,促进细胞增殖,激活重叠但不同的信号通路,协同促进乳腺肿瘤的发生和发展。使用我们独特的模型,包括MCF7细胞衍生的亚系,已经被设计为PRL产生不足或有条件地过表达PRL,以及我们的转基因小鼠在非激素调控的乳腺富含启动子的控制下过表达PRL、TGFa或PRL和TGFa,我们建议:1:在体外比较PRL和E2的作用,并研究它们在细胞周期动力学、细胞周期蛋白D1信号转导以及导致增殖的信号串扰中的相互作用。2:利用我们的高表达PRL和/或TGFa的转基因小鼠,在体内探索肿瘤发生过程中E2和PRL之间的相互作用,以检测E2和ERA在肿瘤发生和发展中的作用,并确定在有或没有E2的情况下活跃的靶基因和信号通路;3:利用Cyclin D1-/-小鼠株,检测Cyclin D1在E2调控PRL、TGFa和PRL/TGFa诱导的乳腺癌发生中的作用。这些研究将增加我们对这些因素如何在乳腺肿瘤发病机制中协同作用的理解,并设计出临床有用的方法。
英文摘要
DESCRIPTION (provided by applicant): While prolactin (PRL) plays important roles in the normal mammary gland, its role in human breast cancer remains poorly understood. Despite elevated PRL receptors in human tumors, epidemiological studies correlating circulating PRL to disease have been inconsistent, and bromocriptine treatment to block pituitary PRL had no consistent clinical effect. However, local production of PRL in human breast tissue, permitting autocrine/paracrine activity, was not addressed in these studies. In the previous grant period, we showed that PRL stimulates the mammary cell cycle in vitro by modulating the expression of cyclin D1 and p21, and described a web of signaling pathways that orchestrate this process. Further, overexpression of PRL within mammary epithelial cells in vivo leads to tumorigenesis, and PRL influences TGFa-induced mammary carcinogenesis to decrease tumor latency. Our findings support a role for PRL in the increased proliferation in breast cancer, and provide models to examine mechanisms and interactions with other factors in this disease. Hypothesis: PRL and estradiol (E2) synergistically promote mammary tumor development and progression, via stimulation of expression and activity of cell cycle regulators leading to increased cellular proliferation, and activation of overlapping, but distinct signaling pathways. Using our unique models, including MCF7 cell-derived sublines that have been engineered to be deficient in PRL production or to conditionally overexpress PRL, and our transgenic mice that overexpress PRL, TGFa, or PRL and TGFa under the control of a non-hormonally regulated mammary enriched promoter, we propose to: 1: Compare the actions of PRL and E2 in vitro, and examine their interactions in cell cycle kinetics, signaling to cyclin D1, as well as signaling crosstalk leading to proliferation. 2: Explore interactions between E2 and PRL in vivo during tumorigenesis, using our transgenic mice overexpressing PRL and/or TGFa, to examine the effect of E2 and ERa on tumor development and progression, and identify target genes and signaling pathways that are active in the presence or absence of E2, and 3: Examine the role of cyclin D1 in E2 modulation of PRL, TGFa, and PRL/TGFa-induced mammary carcinogenesis, taking advantage of the cyclin D1-/- mouse strain. These studies will increase our understanding of how these factors may cooperate in the pathogenesis of mammary neoplasia, and design of clinically useful approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Matrix density promotes pro-tumorigenc hormone actions in breast cancer
  • 批准号:
    9228974
  • 项目类别:
  • 资助金额:
    $46.52万
  • 财政年份:
    2014
  • 负责人:
    LINDA A. SCHULER
  • 依托单位:
Matrix density promotes pro-tumorigenc hormone actions in breast cancer
  • 批准号:
    9379069
  • 项目类别:
  • 资助金额:
    $6.24万
  • 财政年份:
    2014
  • 负责人:
    LINDA A. SCHULER
  • 依托单位:
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas
  • 批准号:
    8677796
  • 项目类别:
  • 资助金额:
    $29.89万
  • 财政年份:
    2011
  • 负责人:
    LINDA A. SCHULER
  • 依托单位:
Prolactin: mammary progenitors and tumor initiating cells in luminal carcinomas
  • 批准号:
    8298139
  • 项目类别:
  • 资助金额:
    $30.81万
  • 财政年份:
    2011
  • 负责人:
    LINDA A. SCHULER
  • 依托单位:
海外基金